These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 23399361)

  • 1. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection.
    Romanò L; Velati C; Cambiè G; Fomiatti L; Galli C; Zanetti AR;
    Blood Transfus; 2013 Apr; 11(2):281-8. PubMed ID: 23399361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
    van de Laar TJ; Hogema BM; Molenaar-de Backer MW; Marijt-van der Kreek T; Zaaijer HL
    Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
    Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of HBV NAT Among HBs Antigen-Negative Blood Donors in Saudi Arabia.
    Alabdallat NG; Bin Dukhyil AAA
    Lab Med; 2018 Oct; 49(4):342-346. PubMed ID: 29767761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.
    Olotu AA; Oyelese AO; Salawu L; Audu RA; Okwuraiwe AP; Aboderin AO
    Virol J; 2016 May; 13():76. PubMed ID: 27150469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
    Niederhauser C; Mansouri Taleghani B; Graziani M; Stolz M; Tinguely C; Schneider P
    Swiss Med Wkly; 2008 Mar; 138(9-10):134-41. PubMed ID: 18330733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen.
    Hennig H; Puchta I; Luhm J; Schlenke P; Goerg S; Kirchner H
    Blood; 2002 Oct; 100(7):2637-41. PubMed ID: 12239179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].
    Boumbaly S; Balde TAL; Semenov AV; Ostankova YV; Serikova EN; Naidenova EV; Valutite DE; Shchemelev AN; Zueva EB; Esaulenko EV; Totolian AA
    Vopr Virusol; 2022 Mar; 67(1):59-68. PubMed ID: 35293189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
    PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature.
    Hedayati-Moghaddam MR; Tehranian F; Mosavat A; Miri R; Ahmadi Ghezeldasht S
    Arch Iran Med; 2024 Jun; 27(6):305-312. PubMed ID: 38855800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult hepatitis B infections among blood donors in Lao PDR.
    Jutavijittum P; Andernach IE; Yousukh A; Samountry B; Samountry K; Thammavong T; Keokhamphue J; Toriyama K; Muller CP
    Vox Sang; 2014 Jan; 106(1):31-7. PubMed ID: 23931585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
    Kuhns MC; Busch MP
    Mol Diagn Ther; 2006; 10(2):77-91. PubMed ID: 16669606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z; Milani S; Sharifi Z
    Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult hepatitis B infection among blood donors from Yaoundé, Cameroon.
    Fopa D; Candotti D; Tagny CT; Doux C; Mbanya D; Murphy EL; Kenawy HI; El Chenawi F; Laperche S
    Blood Transfus; 2019 Nov; 17(6):403-408. PubMed ID: 31846605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.